Compositions and methods for treating purpura
- 专利权人:
- Inc.;Allergan
- 发明人:
- Shanler, Stuart D.,Ondo, Andrew
- 申请号：
- AU2008322411
- 公开号：
- AU2008322411C1
- 申请日:
- 2008.11.17
- 申请国别(地区):
- AU
- 年份:
- 2015
- 代理人:
- 摘要：
- Embodiments of the present invention are directed to compositions and methodsfor the treatment of purpura. Preferred compositions comprise an α adrenergicreceptor agonist selected from selective α
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Compositions and methods for treating purpura
- PYRROLIDINE OR THIAZOLIDINE CARBOXYLIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERS AS AGONISTS OF G-PROTEIN COUPLED RECEPTOR 43 (GPR43)
- Pyrrolidinecarboxylic acid derivatives, pharmaceutical compositions and methods as G-protein coupled receptor 43 (GPR43) agonists used in the treatment of metabolic disorders
- FORMULATIONS D'AGONISTE DES RÉCEPTEURS DE TYPE TOLL ET LEUR UTILISATION
- NOVI POLIMORFNI KRISTALNI OBLICI 5-(2-{[6-(2,2-DIFLUORO-2-FENILETOKSI)HEKSIL]AMINO}-1-(R)-HIDROKSIETIL)-8-HIDROKSIHINOLIN-2(1H)-ONA, HEMINAPADIZILATA KAO AGONIST SS2 ADRENERGIČKOG RECEPTORA
